Predictive Oncology Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q2 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Predictive Oncology Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q2 2024.
  • Predictive Oncology Inc. Entity Common Stock, Shares Outstanding for the quarter ending August 5, 2024 was 6.67M shares, a 65.5% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 6.67M +2.64M +65.5% Aug 5, 2024 10-Q 2024-08-13
Q1 2024 4.06M -75.3M -94.9% Mar 18, 2024 10-K 2024-03-28
Q3 2023 4.06M -74.7M -94.8% Nov 6, 2023 10-Q 2023-11-13
Q2 2023 4.03M -74.4M -94.9% Aug 3, 2023 10-Q 2023-08-10
Q1 2023 79.4M +13.5M +20.5% Mar 14, 2023 10-K 2023-03-21
Q3 2022 78.8M +13.2M +20.1% Nov 4, 2022 10-Q 2022-11-10
Q2 2022 78.4M +13M +19.8% Aug 5, 2022 10-Q 2022-08-11
Q1 2022 65.9M +17.1M +35.1% Mar 24, 2022 10-K 2022-03-31
Q3 2021 65.6M +47.9M +271% Nov 5, 2021 10-Q 2021-11-10
Q2 2021 65.4M +54.8M +514% Aug 6, 2021 10-Q 2021-08-11
Q1 2021 48.8M +42.9M +734% Mar 10, 2021 10-K 2021-03-15
Q3 2020 17.7M +13.8M +355% Nov 11, 2020 10-Q 2020-11-16
Q2 2020 10.6M -20.6M -65.9% Jun 5, 2020 10-Q 2020-06-08
Q1 2020 5.85M -9.94M -63% Mar 27, 2020 10-K 2020-04-01
Q3 2019 3.89M -10.2M -72.4% Nov 14, 2019 10-Q 2019-11-15
Q2 2019 31.3M +17.9M +133% Aug 13, 2019 10-Q 2019-08-19
Q1 2019 15.8M +3.99M +33.8% Mar 26, 2019 10-K/A 2019-04-02
Q3 2018 14.1M +7.81M +124% Nov 12, 2018 10-Q 2018-11-14
Q2 2018 13.4M +7.17M +115% Aug 12, 2018 10-Q 2018-08-14
Q1 2018 11.8M +5.31M +81.9% Mar 19, 2018 10-K 2018-04-02
Q3 2017 6.28M +2.48M +65.1% Nov 14, 2017 10-Q 2017-11-14
Q2 2017 6.23M -75.6M -92.4% Aug 14, 2017 10-Q 2017-08-14
Q1 2017 6.49M -43.4M -87% Mar 15, 2017 10-K 2017-03-15
Q3 2016 3.8M -1.4M -26.9% Oct 30, 2016 10-Q 2016-11-14
Q2 2016 81.8M +78.5M +2369% Aug 3, 2016 10-Q 2016-08-12
Q1 2016 49.9M +46.8M +1488% Mar 16, 2016 10-K 2016-03-16
Q3 2015 5.2M +2.18M +72.2% Oct 13, 2015 10-Q/A 2015-12-09
Q2 2015 3.31M -220M -98.5% Aug 6, 2015 10-Q 2015-08-10
Q1 2015 3.14M -218M -98.6% Apr 24, 2015 10-K 2015-04-30
Q3 2014 3.02M -218M -98.6% Nov 3, 2014 10-Q 2014-11-12
Q2 2014 223M +101M +82.8% Aug 4, 2014 10-Q 2014-08-08
Q1 2014 222M +101M +84.1% Mar 17, 2014 10-K 2014-03-27
Q3 2013 221M +122M +123% Nov 6, 2013 10-Q 2013-11-14
Q2 2013 122M +54.6M +81.2% Aug 8, 2013 10-Q 2013-08-14
Q1 2013 120M +81.7M +212% Mar 20, 2013 10-K 2013-03-22
Q3 2012 99.1M +68.6M +226% Nov 5, 2012 10-Q 2012-11-15
Q2 2012 67.3M +39.5M +142% Aug 13, 2012 10-Q/A 2012-08-24
Q1 2012 38.6M Apr 10, 2012 10-K 2012-04-16
Q3 2011 30.4M Nov 1, 2011 10-Q 2011-11-14
Q2 2011 27.8M Aug 3, 2011 10-Q/A 2011-08-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.